Cost-Effectiveness of Apomorphine Sublingual Film as an “On-Demand” Treatment for “OFF” Episodes in Patients with Parkinson's Disease
# Background “On-demand” treatments approved in the United States (US) for “OFF” episodes in Parkinson’s disease (PD) include apomorphine hydrochloride injection (SC-APO), apomorphine sublingual film (APL), and levodopa inhalation powder (CVT-301). APL received US approval in 2020, and its cost-effe...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Columbia Data Analytics, LLC
2021-11-01
|
| シリーズ: | Journal of Health Economics and Outcomes Research |
| オンライン･アクセス: | https://doi.org/10.36469/jheor.2021.29488 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|